The leading pharmaceutical company, ‘Moderna’ has said that it is confident that new vaccines for cancer, cardiovascular and autoimmune diseases, and other conditions will be ready by 2030, potentially saving millions of lives.
Moderna, the company that created a successful COVID-19 vaccine, is working on cancer vaccines targeting different tumour types.
These vaccines work by identifying protein fragments on the surface of cancer cells that are not present on healthy cells and then creating pieces of mRNA to instruct the body on how to manufacture them.
This process results in a personalised vaccine for the patient.
The mRNA molecule teaches cells how to make proteins, and by injecting a synthetic form, cells can pump out proteins that trigger the immune response against disease.
The accelerated progress in mRNA technology seen over the past 12 to 18 months has been aided by the success of COVID-19 vaccines.
Moderna’s chief medical officer, Dr Paul Burton, said he believes the company will be able to offer personalised cancer vaccines and therapies for rare diseases in as little as five years.
#MaltaDaily